Surrogate gene therapy for muscular dystrophy
An engineered truncated gene derived from the dystrophin-related protein (utrophin), prevents pathology without an immune response in an animal model of Duchenne muscular dystrophy (DMD) gene therapy.
Main Authors: | Davies, KE, Chamberlain, JS |
---|---|
格式: | Journal article |
語言: | English |
出版: |
Springer Nature
2019
|
相似書籍
-
Therapeutic approaches to muscular dystrophy.
由: Goyenvalle, A, et al.
出版: (2011) -
The Pathogenesis and Therapy of Muscular Dystrophies
由: Guiraud, S, et al.
出版: (2015) -
Progress in therapy for Duchenne muscular dystrophy.
由: Fairclough, R, et al.
出版: (2011) -
Progress in therapy for Duchenne muscular dystrophy
由: Fairclough, R, et al.
出版: (2011) -
Utrophin in the therapy of Duchenne Muscular Dystrophy
由: Potter, A, et al.
出版: (2006)